InhaleRx Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was AUD 0.18174 million compared to AUD 0.022127 million a year ago. Net loss was AUD 1.11 million compared to AUD 1.21 million a year ago.

Basic loss per share from continuing operations was AUD 0.00663 compared to AUD 0.01215 a year ago. Diluted loss per share from continuing operations was AUD 0.00663 compared to AUD 0.01215 a year ago.